Addus HomeCare (ADUS) Management Meeting Implies Upside to 2020 Estimates - Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Michael Wiederhorn reiterated an Outperform rating and $91 price target on Addus HomeCare (NASDAQ: ADUS) after meeting with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
